-

LISA Laser New Holmium and Thulium Laser Fibers Produced in the USA

original (Graphic: Business Wire)

(Graphic: Business Wire)

BILLERICA, Mass.--(BUSINESS WIRE)--OmniGuide Holding, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announces the commercial launch of LISA Laser Urology Holmium and Thulium Fibers produced in the USA.

“OmniGuide Holding and its affiliate LISA Laser Products GmbH continued to put patients first, invest to simplify operations, and deliver to LISA Laser Urology customers the quality expected from our global brand. We understand fast delivery and competitive pricing for LISA Laser Holmium and Thulium Laser Fibers is important,” said Matthew Henderson, President and CEO of OmniGuide Holding. “LISA Laser Urology customers now can expect a fiber delivered to their facility within 24 – 48 hours from order to delivery by our manufacturing site in Billerica, MA.”

“LISA Laser genuine fibers made directly in the USA - Empowering facilities with easy access to LISA Laser patient solutions, with more than 600 published clinical papers - LISA Global Urology organization is committed to innovation,” said Giorgio Brusa OmniGuide Holding Global Marketing Vice President. “We look forward to the USA launch in 2021 of the LISA Laser family of revolutionary Thulium Lasers technology’s for Stone Management and BPH, and celebrate delivering on the promise of improved patient outcomes.”

About OmniGuide Inc.

OmniGuide, Inc. is a patient safety-focused medical technology innovator, providing a portfolio of advanced energy surgical tools to benefit clinicians and their patients alike. The company’s technologies deliver energy in a precise and electrically silent manner, resulting in the preservation of healthy tissue.

OmniGuide Surgical, a leader in flexible fiber CO2 laser technology, offers a range of products designed to enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgery.

Domain Surgical, by OmniGuide, Inc., provides a patented ferromagnetic technology designed to provide safety and predictability in select surgical procedures that require cutting, coagulating and sealing of tissue.

LISA Laser Products GmbH, a leader in holmium and thulium laser technology, offers a wide range of products focused on improving clinical and patient outcomes in otolaryngology, neuro and urological surgical procedures.

Contacts

Marketing Team
OmniGuide, Inc.
+1 617-551-8571
Marketing@omni-guide.com
www.omni-guide.com

Industry:

OmniGuide Holding

Release Versions
English

Contacts

Marketing Team
OmniGuide, Inc.
+1 617-551-8571
Marketing@omni-guide.com
www.omni-guide.com

More News From OmniGuide Holding

European Patent Office Grants OmniGuide with patent for its Laparoscopic Handpiece for FlexAssure CO2 Flexible Instruments and Fibers

BOSTON--(BUSINESS WIRE)--The European Patent Office granted OmniGuide with a new patent for its Laparoscopic Handpiece for FlexAssure CO2 Flexible Instruments (Patent Number 3193695). Laparoscopy is a surgical approach that allows a surgeon to access the inside of the human body without making large incisions. These procedures are widely adopted worldwide for their patient benefits including smaller surgical scars, quicker recovery, and decreased post procedure pain. OmniGuide FlexAssure CO2 Fl...

German Federal Ministry of Education and Research awards grants to fund a clinical trial for LISA Laser innovated “novel treatment of urolithiasis”

GÖTTINGEN, Germany--(BUSINESS WIRE)--On the 26th of August 2022, the German Federal Ministry of Education and Research selected a “novel approach for the treatment of urolithiasis” for funding (Grant No. 13GW0628). Urolithiasis (urinary stone formation) is a common disease affecting about 12% of the global population. Consequently, urolithiasis is a widespread disease with significant socioeconomic impact and is relevant to healthcare in terms of society and health policy. LISA Laser Products G...

OmniGuide Holdings Receives FDA Clearance for RevoLix™ HTL Hybrid Thulium Laser for the treatment of BPH and Stones

BILLERICA, Mass.--(BUSINESS WIRE)--OmniGuide Holdings (OGH) Today, the U.S. Food and Drug Administration cleared RevoLix™ HTL a family of pulsed and continuous wave Thulium YAG lasers is the foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures. “The FDA's clearance reflects our confidence in our unique RevoLix™ HTL therapy and our efforts into surgical laser innovation, setting new standards in patients' safety,” said Dr. Samir Lamrini Global Directo...
Back to Newsroom